ATYR
ATYR
NASDAQ · Biotechnology

Atyr Pharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.90
+0.09 (+10.89%)
As of Feb 8, 2:13 PM ET ·
Analyst Consensus
Hold
16
Analysts
High
Coverage
Buy 8 50%
Hold 8 50%
Sell 0 0%
Price Target
Analyst Price Target +1,214.8% upside
Low Target $9.31
Average Target $11.82
High Target $19.97
Current Price $0.90
Current
$0.90
Target
$11.82
$9.31 $11.82 avg $19.97
Scenario Analysis
Bear Case
$9.31
935.6%
Low target
Base Case
$11.82
+1,214.8%
Avg target
Bull Case
$19.97
+2,121.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$16.51
-94.6% from high
52-Week Low
$6.89
+-87.0% from low
Target vs 52W High
$11.82
-28.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%